NEW YORK – The World Health Organization has recommended that new point-of-care immunodiagnostic tests for the coronavirus that causes COVID-19 should not be used for clinical decision-making. At present, the tests shouldn't be used outside research settings "until evidence supporting use for specific indications is available," the WHO said in a scientific brief on Wednesday.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.